DARIOHEALTH CORP
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$3.00
-9.37%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-51.3%
3 months
-57.8%
6 months
-58.9%
1 year
-78.0%
Year to date
-73.6%
52-week range
$3.00 – $14.00
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$29.4M
P/E
-0.6
P/B
0.5
P/S
1.4
Revenue
$21M
Net income
-$35.67M
Diluted EPS
-6.13
Gross margin
58.20%
Net margin
-215.60%
Return on equity
-69.60%
Total debt
$32.41M
Cash
$6.63M
Free cash flow
-$25.48M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $5.18M | -$7.92M | 61.70% | -153.10% | -$6.12M |
| Mar 31, 2026 | $5.58M | -$8.25M | 57.30% | -147.70% | -$6.05M |
| Dec 31, 2025 | $5.23M | -$9.03M | 53.60% | -196.00% | -$5.91M |
| Sep 30, 2025 | $5.01M | -$10.47M | 60.20% | -376.60% | -$7.39M |
| Jun 30, 2025 | $5.37M | -$12.99M | 55.20% | -345.70% | -$6.08M |
| Mar 31, 2025 | $6.75M | -$9.23M | 57.50% | -208.30% | -$6.7M |
| Dec 31, 2024 | $7.6M | -$9.63M | 55.30% | -161.20% | -$6.75M |
| Sep 30, 2024 | $7.42M | -$12.33M | 52.20% | -196.80% | -$7.39M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent DRIO news
All market newsNo ticker-linked stories are in the current archive.